

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.52244552 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.40171386 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.15293841 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.87181908 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.85132694 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.36057598 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.33836985 |
| 8 | vocalization behavior (GO:0071625) | 5.30852545 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.29859154 |
| 10 | glutamate secretion (GO:0014047) | 5.27696101 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10612825 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.00046005 |
| 13 | cerebellar granule cell differentiation (GO:0021707) | 4.94358935 |
| 14 | L-amino acid import (GO:0043092) | 4.88725024 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.86341038 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.84302758 |
| 17 | exploration behavior (GO:0035640) | 4.79437801 |
| 18 | protein localization to synapse (GO:0035418) | 4.71558459 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.66094587 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.57815896 |
| 21 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.56398099 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.38467291 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.36554663 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 4.34272453 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.33730974 |
| 26 | amino acid import (GO:0043090) | 4.33168214 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 4.20459613 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.18283910 |
| 29 | regulation of synapse maturation (GO:0090128) | 4.18077143 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 4.16838492 |
| 31 | layer formation in cerebral cortex (GO:0021819) | 4.12811229 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.10296277 |
| 33 | long-term memory (GO:0007616) | 4.07536531 |
| 34 | proline transport (GO:0015824) | 4.07284042 |
| 35 | neuron cell-cell adhesion (GO:0007158) | 4.05430573 |
| 36 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.00188458 |
| 37 | sodium ion export (GO:0071436) | 3.96121948 |
| 38 | positive regulation of membrane potential (GO:0045838) | 3.96074754 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.94734481 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.92988291 |
| 41 | cellular potassium ion homeostasis (GO:0030007) | 3.89229804 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.89137931 |
| 43 | potassium ion homeostasis (GO:0055075) | 3.88100931 |
| 44 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.87757026 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.82745486 |
| 46 | regulation of synaptic plasticity (GO:0048167) | 3.82173454 |
| 47 | axon ensheathment in central nervous system (GO:0032291) | 3.77712487 |
| 48 | central nervous system myelination (GO:0022010) | 3.77712487 |
| 49 | potassium ion import (GO:0010107) | 3.74946547 |
| 50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.70902409 |
| 51 | activation of protein kinase A activity (GO:0034199) | 3.70884075 |
| 52 | positive regulation of synapse maturation (GO:0090129) | 3.69177723 |
| 53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.64725737 |
| 54 | gamma-aminobutyric acid transport (GO:0015812) | 3.62252452 |
| 55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.59054320 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.59004696 |
| 57 | neuromuscular process controlling balance (GO:0050885) | 3.54691939 |
| 58 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.50743658 |
| 59 | long-term synaptic potentiation (GO:0060291) | 3.50405969 |
| 60 | synaptic vesicle endocytosis (GO:0048488) | 3.50400153 |
| 61 | cell communication by electrical coupling (GO:0010644) | 3.47290225 |
| 62 | neurotransmitter transport (GO:0006836) | 3.45536486 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.43742862 |
| 64 | regulation of neurotransmitter secretion (GO:0046928) | 3.41469850 |
| 65 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.40242646 |
| 66 | neuromuscular synaptic transmission (GO:0007274) | 3.39912724 |
| 67 | chemosensory behavior (GO:0007635) | 3.38740224 |
| 68 | cell differentiation in hindbrain (GO:0021533) | 3.37995472 |
| 69 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.36009127 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35359410 |
| 71 | neuron recognition (GO:0008038) | 3.34745409 |
| 72 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.33880603 |
| 73 | cell migration in hindbrain (GO:0021535) | 3.33117605 |
| 74 | regulation of ARF protein signal transduction (GO:0032012) | 3.31791865 |
| 75 | dendritic spine organization (GO:0097061) | 3.31376648 |
| 76 | innervation (GO:0060384) | 3.30062952 |
| 77 | acidic amino acid transport (GO:0015800) | 3.27181331 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 3.27098167 |
| 79 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26828804 |
| 80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.26168284 |
| 81 | glycine transport (GO:0015816) | 3.25114803 |
| 82 | positive regulation of neurotransmitter transport (GO:0051590) | 3.22276682 |
| 83 | regulation of neurotransmitter levels (GO:0001505) | 3.22147606 |
| 84 | axonal fasciculation (GO:0007413) | 3.22030510 |
| 85 | transmission of nerve impulse (GO:0019226) | 3.20923382 |
| 86 | synaptic vesicle transport (GO:0048489) | 3.19743816 |
| 87 | establishment of synaptic vesicle localization (GO:0097480) | 3.19743816 |
| 88 | positive regulation of dendrite development (GO:1900006) | 3.16360216 |
| 89 | behavioral fear response (GO:0001662) | 3.15900450 |
| 90 | behavioral defense response (GO:0002209) | 3.15900450 |
| 91 | dendrite morphogenesis (GO:0048813) | 3.15748161 |
| 92 | synaptic transmission (GO:0007268) | 3.14695358 |
| 93 | vesicle docking involved in exocytosis (GO:0006904) | 3.14426869 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.14338166 |
| 95 | regulation of neurotransmitter transport (GO:0051588) | 3.13105943 |
| 96 | membrane depolarization (GO:0051899) | 3.12181677 |
| 97 | neurotransmitter uptake (GO:0001504) | 3.11904090 |
| 98 | regulation of dendrite morphogenesis (GO:0048814) | 3.09299576 |
| 99 | positive regulation of dendritic spine development (GO:0060999) | 3.09088146 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.08361060 |
| 101 | neuronal ion channel clustering (GO:0045161) | 3.07949844 |
| 102 | auditory behavior (GO:0031223) | 3.07377405 |
| 103 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.05291230 |
| 104 | regulation of exocytosis (GO:0017157) | 3.05175426 |
| 105 | regulation of synaptic transmission (GO:0050804) | 3.05174107 |
| 106 | cerebellar Purkinje cell layer development (GO:0021680) | 3.04956335 |
| 107 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.03998096 |
| 108 | positive regulation of synaptic transmission (GO:0050806) | 3.03667397 |
| 109 | vesicle transport along microtubule (GO:0047496) | 3.03065448 |
| 110 | fear response (GO:0042596) | 3.02467029 |
| 111 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.00822967 |
| 112 | regulation of dendritic spine development (GO:0060998) | 2.98386714 |
| 113 | postsynaptic membrane organization (GO:0001941) | 2.97937385 |
| 114 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.97234538 |
| 115 | learning (GO:0007612) | 2.97133726 |
| 116 | positive regulation of vesicle fusion (GO:0031340) | 2.96432490 |
| 117 | response to auditory stimulus (GO:0010996) | 2.95634333 |
| 118 | neuromuscular process (GO:0050905) | 2.94890961 |
| 119 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.94189925 |
| 120 | cellular sodium ion homeostasis (GO:0006883) | 2.93071519 |
| 121 | membrane hyperpolarization (GO:0060081) | 2.92400737 |
| 122 | intraspecies interaction between organisms (GO:0051703) | 2.91779367 |
| 123 | social behavior (GO:0035176) | 2.91779367 |
| 124 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.90389555 |
| 125 | detection of calcium ion (GO:0005513) | 2.90274193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.29996137 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15304300 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08408698 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04608480 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01872681 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.00622656 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.91461206 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75494096 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75494096 |
| 10 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.75171632 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73942661 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.62648003 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60388712 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.60050583 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44664766 |
| 16 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.42985480 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42122411 |
| 18 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40287988 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33761617 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33532214 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31267243 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.28402018 |
| 23 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26531116 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26282843 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.15826096 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11583036 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01386385 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93437285 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79649014 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57356859 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52317177 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46874883 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46573473 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43671419 |
| 35 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.43403655 |
| 36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42792342 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41154105 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38838875 |
| 39 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.36168160 |
| 40 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36134395 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35921713 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35816576 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34140085 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32763590 |
| 45 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32347917 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32165889 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29924832 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29508006 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27776925 |
| 50 | AR_19668381_ChIP-Seq_PC3_Human | 1.26531559 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24575903 |
| 52 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.20399158 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19364067 |
| 54 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18826055 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17968840 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17042323 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16706764 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16566175 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14895272 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14798504 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12228802 |
| 62 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12165684 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11536558 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08220765 |
| 65 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08157702 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07007229 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04855807 |
| 68 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04104114 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04032261 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03258888 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03125905 |
| 72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02533717 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02329226 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01593143 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01139635 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00288883 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98974325 |
| 78 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97931248 |
| 79 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97516290 |
| 80 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.96497650 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96083742 |
| 82 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95750044 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95720942 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95249839 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94980645 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94429984 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94331274 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93863562 |
| 89 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93138490 |
| 90 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92424237 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92397856 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91517367 |
| 93 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91477572 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91461243 |
| 95 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91403455 |
| 96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91369994 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91276236 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91231721 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90965234 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90197564 |
| 101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89535639 |
| 102 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89287386 |
| 103 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88992485 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88817539 |
| 105 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88634621 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88587277 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 0.88419292 |
| 108 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87184644 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86737257 |
| 110 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86676425 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85152364 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84220810 |
| 113 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83904890 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83867587 |
| 115 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.82958297 |
| 116 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82753353 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82550689 |
| 118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82167923 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81856842 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81728932 |
| 121 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81619557 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81450801 |
| 123 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.80766356 |
| 124 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79938293 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.75533718 |
| 126 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.74484436 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74417185 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73745921 |
| 129 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73208238 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71237500 |
| 131 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.70957555 |
| 132 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68961739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.55706270 |
| 2 | MP0003880_abnormal_central_pattern | 4.46116902 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.33832440 |
| 4 | MP0004270_analgesia | 3.94763448 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47491528 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.45577740 |
| 7 | MP0002822_catalepsy | 3.33159100 |
| 8 | MP0002064_seizures | 3.16749229 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.80428544 |
| 10 | MP0009046_muscle_twitch | 2.67882926 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.67300159 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.60124332 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.46851909 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.46775320 |
| 15 | MP0002272_abnormal_nervous_system | 2.45827448 |
| 16 | MP0001486_abnormal_startle_reflex | 2.40976744 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.39862182 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.17182625 |
| 19 | MP0004858_abnormal_nervous_system | 2.03887434 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.03370153 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.01832679 |
| 22 | MP0003329_amyloid_beta_deposits | 1.93246431 |
| 23 | MP0008569_lethality_at_weaning | 1.92716044 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.91854292 |
| 25 | MP0002736_abnormal_nociception_after | 1.90782073 |
| 26 | MP0001970_abnormal_pain_threshold | 1.85817263 |
| 27 | * MP0004811_abnormal_neuron_physiology | 1.81115956 |
| 28 | MP0003879_abnormal_hair_cell | 1.71884048 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.71743049 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.68563643 |
| 31 | MP0000778_abnormal_nervous_system | 1.68041143 |
| 32 | MP0002184_abnormal_innervation | 1.65549734 |
| 33 | MP0004924_abnormal_behavior | 1.64751661 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.64751661 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.62160707 |
| 36 | MP0003787_abnormal_imprinting | 1.56352219 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.52497537 |
| 38 | * MP0000955_abnormal_spinal_cord | 1.50807245 |
| 39 | MP0003633_abnormal_nervous_system | 1.45457764 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.37616593 |
| 41 | MP0003283_abnormal_digestive_organ | 1.36459411 |
| 42 | MP0004885_abnormal_endolymph | 1.35652809 |
| 43 | * MP0002882_abnormal_neuron_morphology | 1.35386126 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.30668598 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.29982803 |
| 46 | MP0003075_altered_response_to | 1.27240163 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.20871209 |
| 48 | MP0003631_nervous_system_phenotype | 1.16819453 |
| 49 | MP0001984_abnormal_olfaction | 1.14982531 |
| 50 | MP0001529_abnormal_vocalization | 1.12719912 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.12129679 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.10782229 |
| 53 | MP0003122_maternal_imprinting | 1.10135315 |
| 54 | MP0002152_abnormal_brain_morphology | 1.06715431 |
| 55 | MP0002069_abnormal_eating/drinking_beha | 1.05669910 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.04944386 |
| 57 | MP0001905_abnormal_dopamine_level | 1.02944692 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.02426000 |
| 59 | MP0004142_abnormal_muscle_tone | 0.98631758 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 0.94131584 |
| 61 | MP0005535_abnormal_body_temperature | 0.92728779 |
| 62 | MP0001348_abnormal_lacrimal_gland | 0.92507855 |
| 63 | MP0008872_abnormal_physiological_respon | 0.91136014 |
| 64 | MP0004510_myositis | 0.91077807 |
| 65 | MP0001346_abnormal_lacrimal_gland | 0.88891518 |
| 66 | MP0000604_amyloidosis | 0.88770971 |
| 67 | MP0002229_neurodegeneration | 0.88514022 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 0.86324476 |
| 69 | MP0008874_decreased_physiological_sensi | 0.85568682 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.84357135 |
| 71 | MP0000751_myopathy | 0.83964937 |
| 72 | MP0001177_atelectasis | 0.83246606 |
| 73 | MP0004085_abnormal_heartbeat | 0.79624323 |
| 74 | MP0004233_abnormal_muscle_weight | 0.76206521 |
| 75 | MP0003632_abnormal_nervous_system | 0.74978929 |
| 76 | MP0003634_abnormal_glial_cell | 0.74657985 |
| 77 | MP0002653_abnormal_ependyma_morphology | 0.74651077 |
| 78 | MP0005623_abnormal_meninges_morphology | 0.74209765 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.73284428 |
| 80 | MP0002090_abnormal_vision | 0.73149229 |
| 81 | MP0001664_abnormal_digestion | 0.72324280 |
| 82 | MP0004043_abnormal_pH_regulation | 0.71464923 |
| 83 | MP0003690_abnormal_glial_cell | 0.71104955 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.69624162 |
| 85 | MP0004147_increased_porphyrin_level | 0.69133789 |
| 86 | MP0000579_abnormal_nail_morphology | 0.67701333 |
| 87 | MP0002249_abnormal_larynx_morphology | 0.66683258 |
| 88 | MP0005499_abnormal_olfactory_system | 0.66434100 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.66434100 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.65585215 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.64867553 |
| 92 | MP0005187_abnormal_penis_morphology | 0.63476393 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.61843640 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.61676777 |
| 95 | MP0004130_abnormal_muscle_cell | 0.61303551 |
| 96 | MP0001188_hyperpigmentation | 0.61108823 |
| 97 | MP0003861_abnormal_nervous_system | 0.60502553 |
| 98 | MP0002234_abnormal_pharynx_morphology | 0.59836881 |
| 99 | MP0010769_abnormal_survival | 0.59096159 |
| 100 | MP0000920_abnormal_myelination | 0.58436731 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.58276030 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 0.57835800 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.57306462 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.57205505 |
| 105 | MP0001943_abnormal_respiration | 0.56080349 |
| 106 | MP0010768_mortality/aging | 0.55904053 |
| 107 | MP0010770_preweaning_lethality | 0.55823449 |
| 108 | MP0002082_postnatal_lethality | 0.55823449 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.55421326 |
| 110 | MP0004484_altered_response_of | 0.54652855 |
| 111 | MP0003121_genomic_imprinting | 0.53697711 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.53454282 |
| 113 | MP0008877_abnormal_DNA_methylation | 0.53422133 |
| 114 | MP0003123_paternal_imprinting | 0.53388255 |
| 115 | MP0000566_synostosis | 0.52562187 |
| 116 | MP0004742_abnormal_vestibular_system | 0.52289848 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.51655565 |
| 118 | MP0003938_abnormal_ear_development | 0.51370114 |
| 119 | MP0000026_abnormal_inner_ear | 0.51320255 |
| 120 | MP0003956_abnormal_body_size | 0.50088692 |
| 121 | MP0005409_darkened_coat_color | 0.49594501 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.48702672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.36696151 |
| 2 | Focal motor seizures (HP:0011153) | 7.27749113 |
| 3 | Focal seizures (HP:0007359) | 5.68524205 |
| 4 | Visual hallucinations (HP:0002367) | 5.59536932 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.57940022 |
| 6 | Atonic seizures (HP:0010819) | 4.16252422 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.09020221 |
| 8 | Febrile seizures (HP:0002373) | 4.05802224 |
| 9 | Action tremor (HP:0002345) | 3.98483019 |
| 10 | Absence seizures (HP:0002121) | 3.92486325 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.79849896 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.76486544 |
| 13 | Dialeptic seizures (HP:0011146) | 3.62659584 |
| 14 | Depression (HP:0000716) | 3.54374837 |
| 15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.46450551 |
| 16 | Ankle clonus (HP:0011448) | 3.42980033 |
| 17 | Poor eye contact (HP:0000817) | 3.40915259 |
| 18 | Tetraplegia (HP:0002445) | 3.33327599 |
| 19 | Papilledema (HP:0001085) | 3.32459929 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.29739222 |
| 21 | Broad-based gait (HP:0002136) | 3.27221741 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.21137493 |
| 23 | Limb dystonia (HP:0002451) | 3.18286717 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.15644519 |
| 25 | Postural instability (HP:0002172) | 3.14812156 |
| 26 | Anxiety (HP:0000739) | 3.12505510 |
| 27 | Dysmetria (HP:0001310) | 3.12257604 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.10510959 |
| 29 | Dysdiadochokinesis (HP:0002075) | 3.10049529 |
| 30 | Amblyopia (HP:0000646) | 3.08083573 |
| 31 | Abnormal social behavior (HP:0012433) | 3.04736180 |
| 32 | Impaired social interactions (HP:0000735) | 3.04736180 |
| 33 | Truncal ataxia (HP:0002078) | 2.99224206 |
| 34 | Mutism (HP:0002300) | 2.93119064 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.89902955 |
| 36 | Genetic anticipation (HP:0003743) | 2.86403468 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.84766212 |
| 38 | Torticollis (HP:0000473) | 2.81826362 |
| 39 | Akinesia (HP:0002304) | 2.78463645 |
| 40 | Hyperventilation (HP:0002883) | 2.76742048 |
| 41 | Ventricular fibrillation (HP:0001663) | 2.71046788 |
| 42 | Focal dystonia (HP:0004373) | 2.67936771 |
| 43 | Epileptiform EEG discharges (HP:0011182) | 2.67931519 |
| 44 | Urinary urgency (HP:0000012) | 2.66448950 |
| 45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.64318318 |
| 46 | Sleep apnea (HP:0010535) | 2.61302457 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.61094322 |
| 48 | Stereotypic behavior (HP:0000733) | 2.60478892 |
| 49 | Drooling (HP:0002307) | 2.58064116 |
| 50 | Excessive salivation (HP:0003781) | 2.58064116 |
| 51 | EEG with generalized epileptiform discharges (HP:0011198) | 2.56993992 |
| 52 | Spastic gait (HP:0002064) | 2.55820197 |
| 53 | Hemiparesis (HP:0001269) | 2.55481442 |
| 54 | Bradykinesia (HP:0002067) | 2.54054933 |
| 55 | Hemiplegia (HP:0002301) | 2.53607085 |
| 56 | Annular pancreas (HP:0001734) | 2.48362571 |
| 57 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.48204653 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.48029084 |
| 59 | Hypsarrhythmia (HP:0002521) | 2.46831479 |
| 60 | Intention tremor (HP:0002080) | 2.46563357 |
| 61 | Megalencephaly (HP:0001355) | 2.45549052 |
| 62 | Insomnia (HP:0100785) | 2.45143126 |
| 63 | Diminished motivation (HP:0000745) | 2.41526865 |
| 64 | Peripheral hypomyelination (HP:0007182) | 2.39497064 |
| 65 | Diplopia (HP:0000651) | 2.38954641 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.38954641 |
| 67 | Spastic tetraparesis (HP:0001285) | 2.36778915 |
| 68 | Pointed chin (HP:0000307) | 2.33987121 |
| 69 | Dysmetric saccades (HP:0000641) | 2.32639996 |
| 70 | Craniofacial dystonia (HP:0012179) | 2.32135280 |
| 71 | Impaired vibratory sensation (HP:0002495) | 2.30978828 |
| 72 | Scanning speech (HP:0002168) | 2.24749238 |
| 73 | Bundle branch block (HP:0011710) | 2.24588152 |
| 74 | Choreoathetosis (HP:0001266) | 2.18598986 |
| 75 | Agitation (HP:0000713) | 2.17488653 |
| 76 | Obstructive sleep apnea (HP:0002870) | 2.11629363 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.10594817 |
| 78 | Fetal akinesia sequence (HP:0001989) | 2.06844979 |
| 79 | Pheochromocytoma (HP:0002666) | 2.04776164 |
| 80 | Absent speech (HP:0001344) | 2.03117751 |
| 81 | Progressive inability to walk (HP:0002505) | 2.02641818 |
| 82 | Delusions (HP:0000746) | 1.99547235 |
| 83 | Status epilepticus (HP:0002133) | 1.99379581 |
| 84 | Abnormal EKG (HP:0003115) | 1.99103309 |
| 85 | Generalized myoclonic seizures (HP:0002123) | 1.95218001 |
| 86 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94571776 |
| 87 | Bronchomalacia (HP:0002780) | 1.94080837 |
| 88 | Polyphagia (HP:0002591) | 1.93716256 |
| 89 | Insidious onset (HP:0003587) | 1.93347613 |
| 90 | Termporal pattern (HP:0011008) | 1.93347613 |
| 91 | CNS hypomyelination (HP:0003429) | 1.92678797 |
| 92 | Clonus (HP:0002169) | 1.92331840 |
| 93 | Abnormality of saccadic eye movements (HP:0000570) | 1.91903099 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 1.91478459 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.91478459 |
| 96 | Aplasia of the phalanges of the hand (HP:0009802) | 1.91478459 |
| 97 | Rapidly progressive (HP:0003678) | 1.91252315 |
| 98 | Apathy (HP:0000741) | 1.90911455 |
| 99 | Gait ataxia (HP:0002066) | 1.90759884 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 1.90219604 |
| 101 | Hypercortisolism (HP:0001578) | 1.88885831 |
| 102 | Decreased circulating renin level (HP:0003351) | 1.88269583 |
| 103 | Incomplete penetrance (HP:0003829) | 1.88052851 |
| 104 | Rigidity (HP:0002063) | 1.83854581 |
| 105 | Abnormality of the corticospinal tract (HP:0002492) | 1.83677937 |
| 106 | Resting tremor (HP:0002322) | 1.83514537 |
| 107 | Ankyloglossia (HP:0010296) | 1.82732204 |
| 108 | Psychosis (HP:0000709) | 1.82288633 |
| 109 | Lower limb asymmetry (HP:0100559) | 1.81770545 |
| 110 | Spinal canal stenosis (HP:0003416) | 1.80781486 |
| 111 | Neoplasm of the heart (HP:0100544) | 1.80423798 |
| 112 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79401124 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79401124 |
| 114 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79314213 |
| 115 | Increased circulating renin level (HP:0000848) | 1.78789640 |
| 116 | Turricephaly (HP:0000262) | 1.77720507 |
| 117 | Intellectual disability, profound (HP:0002187) | 1.77186665 |
| 118 | Split foot (HP:0001839) | 1.77147555 |
| 119 | Lower limb amyotrophy (HP:0007210) | 1.76237158 |
| 120 | Hypoventilation (HP:0002791) | 1.74451446 |
| 121 | Abnormality of the periventricular white matter (HP:0002518) | 1.73989675 |
| 122 | Memory impairment (HP:0002354) | 1.72061022 |
| 123 | Dementia (HP:0000726) | 1.70947011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.78394473 |
| 2 | EPHA4 | 4.49422083 |
| 3 | MAP3K9 | 4.11854927 |
| 4 | DAPK2 | 2.85203891 |
| 5 | PRKD3 | 2.80664567 |
| 6 | MAP3K4 | 2.62273288 |
| 7 | MINK1 | 2.58717521 |
| 8 | MARK1 | 2.57771850 |
| 9 | CAMKK1 | 2.57582813 |
| 10 | KSR2 | 2.55491252 |
| 11 | PAK6 | 2.40081173 |
| 12 | MAP2K7 | 1.93987242 |
| 13 | NTRK1 | 1.90992557 |
| 14 | NTRK2 | 1.89035174 |
| 15 | KSR1 | 1.83499209 |
| 16 | DAPK1 | 1.78295180 |
| 17 | RIPK4 | 1.73786912 |
| 18 | MAP2K4 | 1.62350185 |
| 19 | TNIK | 1.58978729 |
| 20 | CDK5 | 1.56981640 |
| 21 | PRPF4B | 1.56371507 |
| 22 | MAP3K13 | 1.44581795 |
| 23 | STK38 | 1.43204499 |
| 24 | SIK2 | 1.39779827 |
| 25 | ARAF | 1.39488654 |
| 26 | MAP3K2 | 1.39417365 |
| 27 | GRK5 | 1.37857733 |
| 28 | TAOK1 | 1.34667388 |
| 29 | MAP3K12 | 1.33303398 |
| 30 | FES | 1.26302755 |
| 31 | PLK2 | 1.25491602 |
| 32 | MAPK13 | 1.16210919 |
| 33 | PRKCG | 1.13964514 |
| 34 | UHMK1 | 1.13413853 |
| 35 | TYRO3 | 1.13072101 |
| 36 | CAMK1 | 1.12513892 |
| 37 | CDK19 | 1.06170303 |
| 38 | PRKCH | 1.04319007 |
| 39 | PNCK | 0.96554852 |
| 40 | CAMKK2 | 0.94171955 |
| 41 | PTK2B | 0.93561836 |
| 42 | RET | 0.93003317 |
| 43 | STK11 | 0.92956374 |
| 44 | RAF1 | 0.91331104 |
| 45 | CAMK2A | 0.87182050 |
| 46 | ALK | 0.83177264 |
| 47 | SGK494 | 0.82068242 |
| 48 | SGK223 | 0.82068242 |
| 49 | MAP3K11 | 0.81946543 |
| 50 | MAP3K1 | 0.81164386 |
| 51 | MARK2 | 0.80977747 |
| 52 | CDK18 | 0.80659972 |
| 53 | CDK15 | 0.78958474 |
| 54 | CAMK1D | 0.78572652 |
| 55 | LATS2 | 0.77211101 |
| 56 | CAMK2B | 0.77086460 |
| 57 | PDK1 | 0.76881373 |
| 58 | MAP3K7 | 0.76193982 |
| 59 | PINK1 | 0.75846382 |
| 60 | BMPR2 | 0.75285579 |
| 61 | PHKG2 | 0.75281130 |
| 62 | PHKG1 | 0.75281130 |
| 63 | CDK14 | 0.74718499 |
| 64 | MAPK12 | 0.72368280 |
| 65 | SGK2 | 0.72142187 |
| 66 | DYRK1A | 0.70662457 |
| 67 | PAK3 | 0.70461819 |
| 68 | SGK3 | 0.70039728 |
| 69 | SCYL2 | 0.69087011 |
| 70 | PKN1 | 0.68093810 |
| 71 | CDK11A | 0.67544971 |
| 72 | SGK1 | 0.67175713 |
| 73 | PDPK1 | 0.66770804 |
| 74 | OXSR1 | 0.65505488 |
| 75 | CASK | 0.64764197 |
| 76 | FGFR2 | 0.63599788 |
| 77 | BRSK1 | 0.62785346 |
| 78 | PASK | 0.62184486 |
| 79 | CAMK1G | 0.61787605 |
| 80 | RIPK1 | 0.58594129 |
| 81 | NME1 | 0.54842583 |
| 82 | LMTK2 | 0.54375039 |
| 83 | CDC42BPA | 0.54306308 |
| 84 | MAP2K1 | 0.54061997 |
| 85 | NEK6 | 0.53941982 |
| 86 | CAMK4 | 0.52662603 |
| 87 | TRIB3 | 0.52518553 |
| 88 | RPS6KA3 | 0.51296065 |
| 89 | PRKCZ | 0.49415249 |
| 90 | CSNK1G2 | 0.47679761 |
| 91 | FYN | 0.43677228 |
| 92 | LIMK1 | 0.43652390 |
| 93 | DMPK | 0.43519825 |
| 94 | MAPK10 | 0.43458033 |
| 95 | FER | 0.42806572 |
| 96 | SIK3 | 0.42050077 |
| 97 | WNK1 | 0.41756479 |
| 98 | INSRR | 0.41319606 |
| 99 | RPS6KA2 | 0.40898433 |
| 100 | DAPK3 | 0.40876319 |
| 101 | ERBB2 | 0.39627138 |
| 102 | CAMK2D | 0.36755322 |
| 103 | PRKD2 | 0.36429441 |
| 104 | TNK2 | 0.36330994 |
| 105 | ROCK2 | 0.36235013 |
| 106 | ICK | 0.35690105 |
| 107 | MAP3K6 | 0.35587209 |
| 108 | WNK3 | 0.34812250 |
| 109 | TESK1 | 0.34669794 |
| 110 | IRAK2 | 0.34408737 |
| 111 | MAPK8 | 0.34039174 |
| 112 | MAP2K6 | 0.33616542 |
| 113 | PRKCE | 0.33079792 |
| 114 | CAMK2G | 0.31858895 |
| 115 | PRKCA | 0.31194766 |
| 116 | BRAF | 0.31055545 |
| 117 | PRKG2 | 0.30174635 |
| 118 | GSK3B | 0.25666178 |
| 119 | PRKCB | 0.22202514 |
| 120 | SRC | 0.22001170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.29941701 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10982056 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78556695 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.75327972 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.74269199 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.52854487 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52000961 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.49512422 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48072005 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.33275518 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.31880484 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30803338 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.20076699 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11073397 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.02698797 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.97539034 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93873320 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69337014 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69297228 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66789917 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60793980 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59568152 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.58513191 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.58119797 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.55671741 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54437630 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.54062980 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.52247753 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47810410 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.46201785 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33008985 |
| 32 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27754348 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.27616523 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.27460481 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25888296 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23918348 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18507925 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12665656 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12036328 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09829891 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09262156 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08537079 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.03835489 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02956955 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98515654 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98230559 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95136551 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91482530 |
| 49 | * Axon guidance_Homo sapiens_hsa04360 | 0.90392103 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87850698 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86627517 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86615368 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84753580 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84717129 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84715417 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84687411 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83171795 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80297920 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77540282 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74901586 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74183214 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70202800 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69252153 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67888841 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67606654 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66811058 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66689604 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.66328518 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62158199 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58592911 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57898178 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55417444 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54906030 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54737011 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.54733656 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53239935 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52763239 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52681185 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52416277 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.52140458 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.51442438 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50205577 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49805226 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49797908 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49319163 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48565974 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.43853048 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42167592 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41102900 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39701826 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37024925 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36604929 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36374955 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35502337 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35484759 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34628783 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33870050 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32741833 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.31800450 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30895443 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30659203 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.29375629 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29292609 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28177712 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28089848 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25917000 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25839830 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25824082 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.23926683 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23364456 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22946944 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22869369 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22309971 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22158622 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17588000 |

